Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells

Biochemical and Biophysical Research Communications

Volumn 316, Issue 1, 2004, Pages 71-77

  Habiro, Atsuya ^a   Tanno, Satoshi ^a   Koizumi, Kazuya ^a   Izawa, Tsutomu ^a   Nakano, Yasuhiro ^a   Osanai, Manabu ^a   Mizukami, Yusuke ^a   Okumura, Toshikatsu ^a   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

AKT; ERK; Gemcitabine; p38 MAPK; Pancreatic cancer

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE; ENZYME ACTIVATOR; GEMCITABINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN FAMILY; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TUMOR; DEOXYCYTIDINE; HUMANS; IMIDAZOLES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PANCREATIC NEOPLASMS; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PYRIDINES;

EID: 1542285510     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.017     Document Type: Article

References (29)

1. Korc M. Role of growth factors in pancreatic cancer. Surg. Oncol. Clin. N. Am. 7:1998;25-41.
2. Burris H.A., Moore M.J., Andersen J., Green M.R., Rothenberg M.L., Modiano M.R., Cripps M.C., Portenoy R.K., Storniolo A.M., Tarassoff P., Nelson R., Dorr F.A., Stephens C.D., Von Hoff D.D. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. 15:1997;2403-2413.
3. Lewis T.S., Shapiro P.S., Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:1998;49-139.
4. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell. 103:2000;239-252.
5. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:2001;807-869.
6. Liu N., Furukawa T., Kobari M., Tsao M.S. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. Am. J. Pathol. 153:1998;263-269.
7. Kato H., Ishikura H., Kawarada Y., Furuya M., Kondo S., Kato H., Yoshiki T. Anti-angiogenic treatment for peritoneal dissemination of pancreas adenocarcinoma: a study using TNP-470. Jpn. J. Cancer Res. 92:2001;67-73.
8. Altomare D.A., Tanno S., De Rienzo A., Klein-Szanto A.J., Tanno S., Skele K.L., Hoffman J.P., Testa J.R. Frequent activation of AKT2 kinase in human pancreatic carcinomas. J. Cell. Biochem. 87:2002;470-476.
9. Tanno S., Tanno S., Mitsuuchi Y., Altomare D.A., Xiao G.H., Testa J.R. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res. 61:2001;589-593.
10. Abbruzzese J.L., Grunewald R., Weeks E.A., Gravel D., Adams T., Nowak B., Mineishi S., Tarassoff P., Satterlee W., Raber M.N. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J. Clin. Oncol. 9:1991;491-498.
11. Enslen H., Raingeaud J., Davis R.J. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273:1998;1741-1748.
12. Germain M., Affar E.B., D'amours D., Dixit V.M., Salvesen G.S., Poirier G.G. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J. Biol. Chem. 274:1999;28379-28384.
13. Persons D.L., Yazlovitskaya E.M., Cui W., Pelling J.C. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin. Cancer Res. 5:1999;1007-1014.
14. ′ -kinase-Akt survival signaling pathway during topotecan-induced apoptosis Cancer Res. 60:2000;5303-5309.
15. Mackeigan J.P., Taxman D.J., Hunter D., Earp H.S., Graves L.M., Ting J.P. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition. Clin. Cancer Res. 8:2002;2091-2099.
16. Kawasaki H., Morooka T., Shimohama S., Kimura J., Hirano T., Gotoh Y., Nishida E. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272:1997;18518-18521.
17. Kummer J.L., Rao P.K., Heidenreich K.A. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272:1997;20490-20494.
18. Yin T., Sandhu G., Wolfgang C.D., Burrier A., Webb R.L., Rigel D., Hai T., Whelan J. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J. Biol. Chem. 272:1997;19943-19950.
19. Adams R.H., Porras A., Alonso G., Jones M., Vintersten K., Panelli S., Valladares A., Perez L., Klein R., Nebreda A.R. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell. 6:2000;109-116.
20. Chen G., Hitomi M., Han J., Stacey D.W. The p38 pathway provides negative feedback for Ras proliferative signaling. J. Biol. Chem. 275:2000;38973-38980.
21. Villunger A., O'reilly L.A., Holler N., Adams J., Strasser A. Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: regulators of distinct cell death and survival pathways in granulocytes. J. Exp. Med. 192:2000;647-658.
22. Benhar M., Dalyot I., Engelberg D., Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell. Biol. 21:2001;6913-6926.
23. Alvarado-Kristensson M., Porn-Ares M.I., Grethe S., Smith D., Zheng L., Andersson T. p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase activities have opposite effects on human neutrophil apoptosis. FASEB J. 16:2002;129-131.
24. Liu R.Y., Fan C., Liu G., Olashawa N.E., Zuckerman K.S. Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-alpha-supported proliferation of leukemia and lymphoma cell lines. J. Biol. Chem. 275:2000;21086-21093.
25. Elenitoba-Johnson K.S., Jenson S.D., Abbott R.T., Palais R.A., Bohling S.D., Lin Z., Tripp S., Shami P.J., Wang L.Y., Coupland R.W., Buckstein R., Perez-Ordonez B., Perkins S.L., Dube I.D., Lim M.S. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc. Natl. Acad. Sci. USA. 100:2003;7259-7264.
26. Nabhan C., Gajria D., Krett N.L., Gandhi V., Ghias K., Rosen S.T. Caspase activation is required for gemcitabine activity in multiple myeloma cell lines. Mol. Cancer Ther. 1:2002;1221-1227.
27. Cheng A., Chan S.L., Milhavet O., Wang S., Mattson M.P. p38 MAP kinase mediates nitric oxide-induced apoptosis of neural progenitor cells. J. Biol. Chem. 276:2001;43320-43327.
28. Junn E., Mourdian M.M. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J. Neurochem. 78:2001;374-383.
29. Iyoda K., Sasaki Y., Horimoto M., Toyama T., Yakushijin T., Sakakibara M., Takehara T., Fujimoto J., Hori M., Wands J.R., Hayashi N. Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer. 97:2003;3017-3026.